Treatment in Schizophrenia: factors for adherence

Detalhes bibliográficos
Autor(a) principal: Francisca Caiado de Bragança
Data de Publicação: 2020
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://hdl.handle.net/10216/128746
Resumo: This narrative review analyzes the existing scientific evidence on factors related to medication adherence in schizophrenia. Using PubMed as the database, a research was conducted targeting articles published between 2009 and 2019, written in English or Portuguese, about predictors of antipsychotic compliance in schizophrenia. Factors affecting adherence have been generally subdivided into 4 categories: disease-related, patient-related, medication-related and environmental-related. Factors which were found to be consistently associated with poor adherence include poverty, high symptom burden, high levels of hostility, poor insight, presence of substance abuse, negative attitudes toward medication and antipsychotic side-effects. On the other hand, variables such as neurocognitive dysfunction, type of antipsychotic, social support and demographic parameters often yielded contradictory results. Variables consistently associated with non-adherence should be assessed in clinical practice and strategies put in place to correct them or dampen their effect. Since conflicting results are often found regarding several studied variables, future research should aim at identifying further predictors of adherence in order to better guide clinicians and maximize the patient's benefit of treatment.
id RCAP_49eda4a3662bada53c5e78865a204bd4
oai_identifier_str oai:repositorio-aberto.up.pt:10216/128746
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Treatment in Schizophrenia: factors for adherenceCiências médicas e da saúdeMedical and Health sciencesThis narrative review analyzes the existing scientific evidence on factors related to medication adherence in schizophrenia. Using PubMed as the database, a research was conducted targeting articles published between 2009 and 2019, written in English or Portuguese, about predictors of antipsychotic compliance in schizophrenia. Factors affecting adherence have been generally subdivided into 4 categories: disease-related, patient-related, medication-related and environmental-related. Factors which were found to be consistently associated with poor adherence include poverty, high symptom burden, high levels of hostility, poor insight, presence of substance abuse, negative attitudes toward medication and antipsychotic side-effects. On the other hand, variables such as neurocognitive dysfunction, type of antipsychotic, social support and demographic parameters often yielded contradictory results. Variables consistently associated with non-adherence should be assessed in clinical practice and strategies put in place to correct them or dampen their effect. Since conflicting results are often found regarding several studied variables, future research should aim at identifying further predictors of adherence in order to better guide clinicians and maximize the patient's benefit of treatment.2020-04-142020-04-14T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttps://hdl.handle.net/10216/128746TID:202613470engFrancisca Caiado de Bragançainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-29T13:48:06Zoai:repositorio-aberto.up.pt:10216/128746Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T23:47:58.868383Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Treatment in Schizophrenia: factors for adherence
title Treatment in Schizophrenia: factors for adherence
spellingShingle Treatment in Schizophrenia: factors for adherence
Francisca Caiado de Bragança
Ciências médicas e da saúde
Medical and Health sciences
title_short Treatment in Schizophrenia: factors for adherence
title_full Treatment in Schizophrenia: factors for adherence
title_fullStr Treatment in Schizophrenia: factors for adherence
title_full_unstemmed Treatment in Schizophrenia: factors for adherence
title_sort Treatment in Schizophrenia: factors for adherence
author Francisca Caiado de Bragança
author_facet Francisca Caiado de Bragança
author_role author
dc.contributor.author.fl_str_mv Francisca Caiado de Bragança
dc.subject.por.fl_str_mv Ciências médicas e da saúde
Medical and Health sciences
topic Ciências médicas e da saúde
Medical and Health sciences
description This narrative review analyzes the existing scientific evidence on factors related to medication adherence in schizophrenia. Using PubMed as the database, a research was conducted targeting articles published between 2009 and 2019, written in English or Portuguese, about predictors of antipsychotic compliance in schizophrenia. Factors affecting adherence have been generally subdivided into 4 categories: disease-related, patient-related, medication-related and environmental-related. Factors which were found to be consistently associated with poor adherence include poverty, high symptom burden, high levels of hostility, poor insight, presence of substance abuse, negative attitudes toward medication and antipsychotic side-effects. On the other hand, variables such as neurocognitive dysfunction, type of antipsychotic, social support and demographic parameters often yielded contradictory results. Variables consistently associated with non-adherence should be assessed in clinical practice and strategies put in place to correct them or dampen their effect. Since conflicting results are often found regarding several studied variables, future research should aim at identifying further predictors of adherence in order to better guide clinicians and maximize the patient's benefit of treatment.
publishDate 2020
dc.date.none.fl_str_mv 2020-04-14
2020-04-14T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/10216/128746
TID:202613470
url https://hdl.handle.net/10216/128746
identifier_str_mv TID:202613470
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799135797630205952